Replies to post #209999 on Biotech Values

[DewDiligence]

GNMX (-55%)—Now we know why today’s PR doesn’t reveal a p-value for the primary endpoint:

$GNMX Primary endpoint graph from presentation pic.twitter.com/ZWT4oY0Cfs

— Vk (@biotechinvstr) March 20, 2017

On the primary endpoint, AEVI-001 performed worse than placebo!